(Q46123564)

English

A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality.

scientific article published on 18 November 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

based on heuristic

inferred from title

Giuseppe Milone

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

M Labopin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

N-C Gorin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E Polge

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Socié

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Gurman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

E Gluckman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

P Jindra

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

X Poiré

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

K Schäfer-Eckart

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

T Ruutu

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

W Arcese

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Mohty

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

V Rocha

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Acute Leukemia Working Party (ALWP) of the European Group for Blood and Marrow Transplantation (EBMT)

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

0 references

publication date

18 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

376-381

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24241579%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

The EBMT activity survey: 1990-2010

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

The EBMT activity survey 2009: trends over the past 5 years.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

The European LeukemiaNet: achievements and perspectives

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société França

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

European survey on clinical use of cord blood for hematopoietic and non-hematopoietic indications

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

21 January 2018

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://pubmed.ncbi.nlm.nih.gov/24241579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24241579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

1 reference

https://pubmed.ncbi.nlm.nih.gov/24241579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haplo-BMT: which approach?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24241579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/24241579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cord blood meets its match

1 reference

https://pubmed.ncbi.nlm.nih.gov/24241579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.178

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46123564&oldid=2207654119"